Finance

Lists
ACET:NASDAQ
Adicet Bio Inc
9,58 USD
+2,19%
(+0,20) 1D
21-авг., 09:41:59 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACET...
Open
9,42 USD
High
9,63 USD
Low
9,42 USD
Mkt. cap
89,54 млн
Avg. vol.
88,38 миң
Volume
672,00
52-wk high
17,44 USD
52-wk low
6,01 USD
EPS
-13,02 USD
Beta
1,60
Shares outstanding
9,36 млн
No. of employees
102
Open
9,42 USD
High
9,63 USD
Low
9,42 USD
Mkt. cap
89,54 млн
Avg. vol.
88,38 миң
Volume
672,00
52-wk high
17,44 USD
52-wk low
6,01 USD
EPS
-13,02 USD
Beta
1,60
Shares outstanding
9,36 млн
No. of employees
102
News stories
From web sources and news partners
About Adicet Bio Inc
CEO-
Employees102
Founded2014
HeadquartersБостон, Массачусетс, Америка Кошмо Штаттары
Sector-
Websiteadicetbio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ACET in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ACET in the last 3 months.
Highest
Current 9,58 USD
27,00 USD (+181,69%)
Average
22,50 USD (+134,74%)
Lowest
18,00 USD (+87,79%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
18,00 USD
+87,8%
08/11/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
27,00 USD
+181,7%
08/10/2026
Boris Peaker
JonesTrading
Buy
Maintained
20,00 USD
+108,7%
08/06/2026
Robert Driscoll
Wedbush
Buy
Reiterated
25,00 USD
+160,8%
08/06/2026
Unknown Analyst
Wedbush
Buy
Reiterated
25,00 USD
+160,8%
08/06/2026
Anthea Li
Jefferies
Buy
Initiated
19,00 USD
+98,2%
05/04/2026
Soumit Roy
JonesTrading
Buy
Maintained
20,00 USD
+108,7%
04/06/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
-
-
03/16/2026
Yatin Suneja
Guggenheim
Buy
Maintained
100,00 USD
+943,3%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,85 млн
25,04 млн
17,49 млн
18,45 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,10 млн
6,85 млн
4,08 млн
3,85 млн
Operating expense
27,95 млн
31,89 млн
21,57 млн
22,30 млн
Total operating expenses
27,95 млн
31,89 млн
21,57 млн
22,30 млн
Operating income
-27,95 млн
-31,89 млн
-21,57 млн
-22,30 млн
Other non operating income
-64,00 миң
-130,00 миң
7,00 миң
-60,00 миң
EBT including unusual items
-26,86 млн
-30,52 млн
-20,24 млн
-21,22 млн
EBT excluding unusual items
-26,86 млн
-30,52 млн
-20,24 млн
-21,22 млн
Income tax expense
-
-
-
143,00 миң
Effective tax rate
-
-
-
-0,67%
Other operating expenses
-
-
-
-
Net income
-26,86 млн
-30,52 млн
-20,24 млн
-21,36 млн
Net profit margin
-
-
-
-
Earnings per share
-4,64
-2,94
-1,88
-1,99
Interest and investment income
1,17 млн
1,52 млн
1,34 млн
1,17 млн
Interest expense
-12,00 миң
-24,00 миң
-23,00 миң
-22,00 миң
Net interest expenses
1,16 млн
1,50 млн
1,32 млн
1,15 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,38 млн
-30,41 млн
-20,23 млн
-21,10 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору